During the past decade, University of Arizona - Clinical and Translational Science Research Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 10 clinical trials were completed, i.e. on average, 111.1% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 7 clinical trials were completed. i.e. 700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Arizona - Clinical and Translational Science Research Center" #1 sponsor was "Pfizer" with 4 trials, followed by "Shire" with 3 trials sponsored, "United Therapeutics" with 3 trials sponsored, "University of Arizona" with 3 trials sponsored and "Celgene" with 3 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Arizona - Clinical and Translational Science Research Center" #1 collaborator was "FDA Office of Orphan Products Development" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University of Arizona - Clinical and Translational Science Research Center" are "Crohn's Disease" (3 trials), "Pulmonary Arterial Hypertension" (3 trials), "Healthy" (2 trials), "Major Depressive Disorder" (2 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "University of Arizona - Clinical and Translational Science Research Center" in a lesser frequency.

Most popular intervention types in "University of Arizona - Clinical and Translational Science Research Center" are "Drug" (14 trials), "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ontamalimab" (2 trials), "nikkomycin Z" (2 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Arizona - Clinical and Translational Science Research Center" are 16 trials for "All" genders.

Currently, there are NaN active trials in "University of Arizona - Clinical and Translational Science Research Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in University of Arizona - Clinical and Translational Science Research Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in University of Arizona - Clinical and Translational Science Research Center, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".